Rationale for earlier and less frequent prostate cancer screening

被引：14

作者：

Carter, HB ^{[1
]}

机构：

[1] Johns Hopkins Univ, Johns Hopkins Hosp,Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA

来源：

UROLOGY | 2001年 / 58卷 / 05期

关键词：

D O I：

10.1016/S0090-4295(01)01390-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：639 / 641

页数：3

共 21 条

[1] The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng./ml.: Relation to biopsy strategy [J].

Babaian, RJ ;

Johnston, DA ;

Naccarato, W ;

Ayala, A ;

Bhadkamkar, VA ;

Fritsch, HA .

JOURNAL OF UROLOGY, 2001, 165 (03) :757-760

[2] Prostate-specific antigen best practice policy - part I: Early detection and diagnosis of prostate cancer [J].

Carroll, P ;

Coley, C ;

McLeod, D ;

Schellhammer, P ;

Sweat, G ;

Wasson, J ;

Zietman, A ;

Thompson, I .

UROLOGY, 2001, 57 (02) :217-224

[3] A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: The only rational approach for men 50 years old and older [J].

Carter, HB .

UROLOGY, 2000, 55 (06) :796-799

[4]

Carter HB, 1997, RECENT ADVANCES IN PROSTATE CANCER AND BPH, P187

[5] Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease [J].

Carter, HB ;

Epstein, JI ;

Partin, AW .

UROLOGY, 1999, 53 (01) :126-130

[6] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].

Catalona, WJ ;

Smith, DS ;

Ornstein, DK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455

[7]

Collins MM, 1997, JAMA-J AM MED ASSOC, V278, P1516, DOI 10.1001/jama.278.18.1516

[8] Low levels of prostate-specific antigen predict long-term risk of prostate cancer: Results from the Baltimore Longitudinal Study of Aging [J].

Fang, JY ;

Metter, EJ ;

Landis, P ;

Chan, DW ;

Morrell, CH ;

Carter, HB .

UROLOGY, 2001, 58 (03) :411-416

[9] Today men with prostate cancer have larger prostates [J].

Feneley, MR ;

Landis, P ;

Simon, I ;

Metter, EJ ;

Morrell, CH ;

Carter, HB ;

Walsh, PC .

UROLOGY, 2000, 56 (05) :839-842

[10]

Gann PH, 1997, EPIDEMIOLOGY, V8, P117

← 1 2 3 →